LYN-defective fibroblasts acquire leukemia-suppressive properties, mediated—at least in part—by a remodeled matrix and the increased expression of THBS1, which induces CLL cell death. The gene discussed is THBS1; the disease is B-cell chronic lymphocytic leukemia.